First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial

Saved in:
Bibliographic Details
Main Authors: Kaufmann, Manfred (Author) , Maass, Nicolai (Author) , Costa, Serban-Dan (Author)
Other Authors: Schneeweiss, Andreas (Other) , Loibl, Sibylle (Other) , Sütterlin, Marc (Other) , Schrader, Iris (Other) , Gerber, Bernd (Other) , Bauer, Wolfgang (Other) , Wiest, Wolfgang (Other) , Tomé, Oliver (Other) , Distelrath, Andrea (Other) , Hagen, Volker (Other) , Kleine-Tebbe, Anke (Other) , Ruckhäberle, Eugen (Other) , Mehta, Keyur (Other) , Minckwitz, Gunter von (Other)
Format: Article (Journal)
Language:English
Published: 2010
In: The European journal of cancer
Year: 2010, Volume: 46, Issue: 18, Pages: 3184-3191
ISSN:0959-8049
Online Access: Get full text
Author Notes:$hM. Kaufmann, N. Maass, S.D. Costa, A. Schneeweiss, S. Loibl, M. W. Sütterlin, I. Schrader, B. Gerber, W. Bauer, W. Wiest, O. Tomé, A. Distelrath, V. Hagen, A. Kleine-Tebbe, E. Ruckhaeberle, K. Mehta, G. von Minckwitz, for the GBG-39 trialists